Showing results (291-300 of 329) with videos related to
Sort By:
Pageof 33
Stroke|December 24, 2017
Effect of Smoking and Folate Levels on the Efficacy of Folic Acid Therapy in Prevention of Stroke in Hypertensive MenZiyi Zhou, Jianping Li, Yaren Yu, et al.Circulation|November 13, 2020
Effect of Dapagliflozin on Clinical Outcomes in Patients With Chronic Kidney Disease, With and Without Cardiovascular DiseaseJohn J V McMurray, David C Wheeler, Bergur V Stefánsson, et al.Nature Medicine|August 20, 2020
Author Correction: Seroprevalence of immunoglobulin M and G antibodies against SARS-CoV-2 in ChinaXin Xu, Jian Sun, Sheng Nie, et al.JACC. Heart Failure|June 30, 2022
Increase in BNP in Response to Endothelin-Receptor Antagonist Atrasentan Is Associated With Incident Heart FailureJ David Smeijer, Jeroen Koomen, Donald E Kohan, et al.Clinical Kidney Journal|August 12, 2024
Inverse association between serum chloride levels and the risk of atrial fibrillation in chronic kidney disease patientsYangang Gan, Sheng Nie, Mingzhen Pang, et al.Clinical Pharmacology and Therapeutics|July 27, 2022
Organic Anion Transporter Gene Variants Associated With Plasma Exposure and Long-Term Response to Atrasentan in Patients With Diabetic Kidney DiseaseJ David Smeijer, Jeroen V Koomen, Donald E Kohan, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 19, 2019
Visit-to-visit variability in blood pressure and the development of chronic kidney disease in treated general hypertensive patientsYoubao Li, Dan Li, Yun Song, et al.Nature Medicine|June 7, 2020
Seroprevalence of immunoglobulin M and G antibodies against SARS-CoV-2 in ChinaXin Xu, Jian Sun, Sheng Nie, et al.BMJ (Clinical Research Ed.)|June 12, 2020
Use of personal protective equipment against coronavirus disease 2019 by healthcare professionals in Wuhan, China: cross sectional studyMin Liu, Shou-Zhen Cheng, Ke-Wei Xu, et al.Lancet (London, England)|April 19, 2019
Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trialHiddo J L Heerspink, Hans-Henrik Parving, Dennis L Andress, et al.Pageof 33